Through analysis of tumor-infiltrating lymphocytes (TIL) by flow cytometry, less amounts of CD45+ immune cells were detected in PTENα-expressing tumors as relative to control tumors (Fig. 2c). The gene discussed is PTPRC; the disease is neoplasm.